Skip to content

Post Stroke Epileptic Seizures Risk Forecast

Clinical Diagnostic Criteria of Forecasting Epileptic Seizures in Stroke Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03848273
Acronym
POSTER-1
Enrollment
120
Registered
2019-02-20
Start date
2019-02-20
Completion date
2022-08-31
Last updated
2019-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Stroke Epilepsy, Post Stroke Seizure, Stroke

Keywords

stroke, epilepsy, seizure, EEG

Brief summary

Improve the effectiveness of treatment and prognosis in patients with cerebrovascular accident by early detection of the risk of developing epileptic seizures.

Interventions

None listed

Sponsors

Lviv National Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* informed consent to participate in the study signed by the patient / relative of the patient / the legal representative of the patient * age over 18 years * stroke, confirmed by neuroimaging * light to moderate stroke (score on National Institutes of Health Stroke Scale).

Exclusion criteria

* recanalization therapy * previous epileptic seizures and history of epilepsy * psychiatric diseases in history * previous stroke * traumatic brain injury * brain tumors. * inflammatory and infectious diseases * decompensated physical illness. * pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
First epileptic seizure1 yearPatient's dairy will be used to assess this outcome measure.

Secondary

MeasureTime frameDescription
Longest seizure-free period1 yearPatient's dairy will be used to assess this outcome measure.

Other

MeasureTime frameDescription
Death1 yearCoroner report will be used to assess this outcome measure.

Countries

Ukraine

Contacts

Primary ContactAndriy Kuzminskyy, M.D.
a.kuzminskyy@gmail.com+380973192791

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026